Clinical Trial Update: AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

View source ↗

Summary

An ongoing clinical trial evaluating AI-based assessment and prediction of pathologic complete response in HER2-positive breast cancer using PET/MRI, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: HER2 Positive Breast Carcinoma | Status: RECRUITING